Sensitization of cisplatin-resistant ovarian cancer cells by magnetite iron oxide nanoparticles: an in vitro study

被引：13

作者：

Gokduman, Kurtulus ^{[1
,2
]}

机构：

[1] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Engn Med, Boston, MA 02114 USA

[2] Bogazici Univ, Inst Biomed Engn, TR-34684 Istanbul, Turkey

来源：

NANOMEDICINE | 2019年 / 14卷 / 24期

关键词：

caspase-3; cisplatin; Fe3O4; magnetite nanoparticles; MTT assay; ovarian cancer; OVCAR-3; SKOV-3; REDOX STATE UNBALANCE; ALPHA-LIPOIC ACID; OXIDATIVE STRESS; INDUCED NEPHROTOXICITY; ENERGETIC METABOLISM; FE3O4; NANOPARTICLES; MITOCHONDRIAL-DNA; DRUG-RESISTANCE; MECHANISMS; GLUTATHIONE;

D O I：

10.2217/nnm-2019-0126

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Aim: To investigate potential of magnetite iron oxide nanoparticles (MION) to sensitize cisplatin-resistant ovarian cancer cells to cisplatin, which to the best of found knowledge has not been reported previously. Materials & methods: MION with a diameter of approximately 20 nm were synthesized, and characterized using Fourier transform infrared spectroscopy, powder x-ray diffraction and particle size analyzer. Results: The synthesized MION have increased reactive oxygen species levels and decreased glutathione levels in cisplatin-resistant ovarian cancer cells (OVCAR-3 and SKOV-3). Using MTT, capsase-3 activity and live/dead assays, capability of the synthesized MION to sensitize cisplatin-resistant ovarian cancer cells has been illustrated. Conclusion: Thus, for further investigations, the synthesized MION can be considered as a potent agent enabling much more effective cisplatin-based therapies for ovarian cancer.

引用

页码：3177 / 3191

页数：15

共 70 条

[1] Molecular Mechanisms behind Free Radical Scavengers Function against Oxidative Stress
Ahmadinejad, Fereshteh
Moller, Simon Geir
Hashemzadeh-Chaleshtori, Morteza
Bidkhori, Gholamreza
Jami, Mohammad-Saeid
[J]. ANTIOXIDANTS, 2017, 6 (03)
[2] American Type Culture Collection (ATCC), 2019, SKOV 3 ATCC HTB 77
[3] American Type Culture Collection (ATCC), 2019, NIH OVCAR 3 ATCC R H
[4] Dichloro-dihydro-fluorescein diacetate (DCFH-DA) assay: A quantitative method for oxidative stress assessment of nanoparticle-treated cells
Aranda, A.
Sequedo, L.
Tolosa, L.
Quintas, G.
Burello, E.
Castell, J. V.
Gombau, L.
[J]. TOXICOLOGY IN VITRO, 2013, 27 (02) : 954 - 963
[5] Enhanced antibacterial activity of iron oxide magnetic nanoparticles treated with Argemone mexicana L. leaf extract: An in vitro study
Arokiyaraj, S.
Saravanan, M.
Prakash, N. K. Udaya
Arasu, M. Valan
Vijayakumar, B.
Vincent, S.
[J]. MATERIALS RESEARCH BULLETIN, 2013, 48 (09) : 3323 - 3327
[6] Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21 and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines
Baharuddin, Puteri
Satar, Nazilah
Fakiruddin, Kamal Shaik
Zakaria, Norashikin
Lim, Moon Nian
Yusoff, Narazah Mohd
Zakaria, Zubaidah
Yahaya, Badrul Hisham
[J]. ONCOLOGY REPORTS, 2016, 35 (01) : 13 - 25
[7] Characterization of aqueous dispersions of Fe3O4 nanoparticles and their biomedical applications
Cheng, FY
Su, CH
Yang, YS
Yeh, CS
Tsai, CY
Wu, CL
Wu, MT
Shieh, DB
[J]. BIOMATERIALS, 2005, 26 (07) : 729 - 738
[8] Developing a Highly Stable PLGA-mPEG Nanoparticle Loaded with Cisplatin for Chemotherapy of Ovarian Cancer
Cheng, Lihua
Jin, Chengmeng
Lv, Wen
Ding, Qiuping
Han, Xu
[J]. PLOS ONE, 2011, 6 (09):
[9] Caspases: the executioners of apoptosis
Cohen, GM
[J]. BIOCHEMICAL JOURNAL, 1997, 326 : 1 - 16
[10] Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems
Danaei, M.
Dehghankhold, M.
Ataei, S.
Davarani, F. Hasanzadeh
Javanmard, R.
Dokhani, A.
Khorasani, S.
Mozafari, M. R.
[J]. PHARMACEUTICS, 2018, 10 (02)

← 1 2 3 4 5 6 7 →